Get started
Author

Mirco Ros

Observed name: M. Ros
Observed institution: Ca' Foncello Hospital
ORCID: 0000-0002-8786-4615
Observed ORCID: 0000-0002-8786-4615
OpenAlex ID: A5036216056
Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT
2015 · Pierluigi Ciet, Goffredo Serra, et al. · European Radiology · 75
Hyaluronic Acid Improves the Tolerability of Hypertonic Saline in the Chronic Treatment of Cystic Fibrosis Patients: A Multicenter, Randomized, Controlled Clinical Trial
2013 · Mirco Ros, Rosaria Casciaro, et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 57
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium
2022 · Pierluigi Ciet, Silvia Bertolo, et al. · European Respiratory Review · 53
PDF
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
2021 · Carla Colombo, Marco Cipolli, et al. · Infection · 28
PDF
Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging
2017 · Pierluigi Ciet, Silvia Bertolo, et al. · European Respiratory Journal · 28
PDF
Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature
2014 · Rosaria Casciaro, Aldo Naselli, et al. · Journal of Chemotherapy · 25
Diffusion weighted imaging in cystic fibrosis disease: beyond morphological imaging
2016 · Pierluigi Ciet, Goffredo Serra, et al. · European Radiology · 20
Antibiotic resistance evolution of Pseudomonas aeruginosa in cystic fibrosis patients (2010‐2013)
2018 · Francesca Lucca, Margherita Guarnieri, et al. · The Clinical Respiratory Journal · 18
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation
2023 · Francesca Lucca, Valentino Bezzerri, et al. · International Journal of Molecular Sciences · 12
Asymmetric dimethylarginine and related metabolites in exhaled breath condensate of children with cystic fibrosis
2016 · Francesca Lucca, Liviana Da Dalt, et al. · The Clinical Respiratory Journal · 9
Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study
2025 · Sonia Volpi, Maura Ambroni, et al. · International Journal of Molecular Sciences · 6
PDF
Critical Issues in the Management of CRMS/CFSPID Children: A National Real‐World Survey
2025 · Vito Terlizzi, Cristina Fevola, et al. · Pediatric Pulmonology · 6
PDF
Management of respiratory tract exacerbations in people with cystic fibrosis: Focus on imaging
2023 · Nicholas Landini, Pierluigi Ciet, et al. · Frontiers in Pediatrics · 6
PDF
Modulation of immune responses by elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis: data from a compassionate use program
2026 · Francesca Lucca, Anna Pianazzola, et al. · Respiratory Research · 3
Elexacaftor/Tezacaftor/Ivacaftor Efficacy in a Cohort of Italian Patients with CFTR Rare Mutations
2025 · Francesca Lucca, Sonia Volpi, et al. · International Journal of Translational Medicine · 3
Home physiotherapists assisting follow-up treatment in cystic fibrosis: a multicenter observational study
2021 · Anna Brivio, Annalisa Orenti, et al. · Monaldi Archives for Chest Disease · 2
PDF
Inhaled hypertonic saline + hyaluronic acid (HSHA) and HS alone in patients with Cystic Fibrosis (CF): a 2 years retrospective analysis in Treviso’s CF Unit
2017 · Stefano Silveri, Mirco Ros, et al. · European Respiratory Journal · 2
Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population
2026 · Julie Semenchuk, Yumi Naito, et al. · Journal of Cystic Fibrosis · 1
PDF
Lumacaftor/ivacaftor combination therapy for cystic fibrosis: A nationwide survey among clinicians
2017 · Rosaria Casciaro, Stefano Costa, et al. · The Clinical Respiratory Journal · 1
COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID
2025 · Carla Colombo, Paola Medino, et al. · Journal of Cystic Fibrosis
P159 Long COVID in people with cystic fibrosis: a prospective observational study within the Italian Cystic Fibrosis Society
2025 · C. Colombo, P. Medino, et al. · Journal of Cystic Fibrosis
733 Management of children with cystic fibrosis–positive neonatal screening/CFTR-related metabolic syndrome: a national real world survey
2024 · V. Terlizzi, L. Claut, et al. · Journal of Cystic Fibrosis
P081 Comparative analysis of CFTR modulators: unravelling the impact on radiological and clinical outcomes
2024 · I. Comello, F. Lucca, et al. · Journal of Cystic Fibrosis
Fibrosi cistica
2021 · Massimo Maschio, Mirco Ros · Medico e Bambino
Expectations about CFTR modulators among physicians from Italian Cystic fibrosis centers: a survey about the evolution of clinical practice paradigms for cystic fibrosis
2021 · Rosaria Casciaro, Stefano Costa, et al.
PDF
Works count: 34
Citation count: 355
H-index: 9
I10-index: 9
Year
Topic
Type